3,3'-(((5,6-Diaminobenzo[c][1,2,5]thiadiazole-4,7-diyl)bis(4,1-phenylene))bis(oxy))bis(propan-1-ol)

Catalog No. :
ACLCIZ834
CAS No. :
2345630-69-3
Molecular Formula :
C24H26N4O4S
Molecular Weight :
466.56

IUPAC Name:3,3'-(((5,6-diaminobenzo[c][1,2,5]thiadiazole-4,7-diyl)bis(4,1-phenylene))bis(oxy))bis(propan-1-ol)

3,3'-(((5,6-Diaminobenzo[c][1,2,5]thiadiazole-4,7-diyl)bis(4,1-phenylene))bis(oxy))bis(propan-1-ol) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$2556.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,3'-(((5,6-Diaminobenzo[c][1,2,5]thiadiazole-4,7-diyl)bis(4,1-phenylene))bis(oxy))bis(propan-1-ol)
IUPAC Name3,3'-(((5,6-diaminobenzo[c][1,2,5]thiadiazole-4,7-diyl)bis(4,1-phenylene))bis(oxy))bis(propan-1-ol)
MDL No.MFCD33548944
Molecular FormulaC24H26N4O4S
Molecular Weight466.56
SMILESNC1=C(C2=CC=C(OCCCO)C=C2)C3=NSN=C3C(C4=CC=C(OCCCO)C=C4)=C1N
InChI KeySKACMXXBWURLLH-UHFFFAOYSA-N
Synonym3,3'-[[(5,6-Diaminobenzo[c][1,2,5]thiadiazole-4,7-diyl)bis(4,1-phenylene)]bis(oxy)]bis(1-propanol);3,3'-(((5,6-Diaminobenzo[c][1,2,5]thiadiazole-4,7-diyl)bis(4,1-phenylene))bis(oxy))bis(propan-1-ol);3,3’-[[(5,6-Diaminobenzo[c][1,2,5]thiadiazole-4,7-diyl)bis(4,1-phenylene)]bis(oxy)]bis(1-propanol);1-Propanol, 3,3′-[(6-methyl[1,2,5]thiadiazolo[3,4-g]quinoxaline-4,9-diyl)bis(4,1-phenyleneoxy)]bis-
CAS No.2345630-69-3

Synthetic Route by SureRoute

1. ACLCIZ834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLCIZ834 route product structure diagram
    ACLCIZ8342345630-69-3
Inquiry

2. ACLCIZ834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLCIZ834 route product structure diagram
    ACLCIZ8342345630-69-3
Inquiry

Comments (0)